commonly known as an enlarged spleen. This condition is often associated with various immune-related diseases, including autoimmune disorders, chronic infections, and can be a side effect of ...
HOUSTON - FibroBiologics, Inc. (NASDAQ:FBLG), a biotechnology firm specializing in fibroblast-based therapies, has filed a patent application for a new cell-based treatment aimed at splenomegaly, ...